See also this year's filing and all EDGAR filings for this company.
PDF Report 0001439222_2026_Agios_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001439222, Agios Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 942,052,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,775,000 |
| 3 | remainder_Assets | 344,398,000 |
| 4 | LiabilitiesCurrent | 82,206,000 |
| 5 | LiabilitiesNoncurrent | 21,905,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 6,045,007 |
| 8 | SellingGeneralAndAdministrativeExpense | 206,591,215 |
| 9 | ResearchAndDevelopmentExpense | 376,609,757 |
| 10 | remainder_Expenses | 32,589,765 |
| 11 | remainder_Revenues | 49,800,900 |
| 12 | remainder_NetIncome | 468,884,736 |
| 13 | remainder_ComprehensiveNetIncome | 1,357,146 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,297,225,000 |
| 1 | Liabilities | 104,111,000 |
| 2 | Expenses | 621,835,744 |
| 3 | Revenues | 49,800,900 |
| 4 | StockholdersEquity | 1,193,114,000 |
| 5 | NetIncome | -103,150,108 |
| 6 | ComprehensiveNetIncome | -102,471,535 |
| 7 | BaseVar | 1,271,607,263 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.57 |
| 9 | EconomicCapitalRatio | 4.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
